Patents Assigned to Nirmidas Biotech, Inc.
  • Assays, sensing platforms, and methods for diagnosis of coronavirus infection and re-infection
    Patent number: 11644465
    Abstract: Disclosed herein are methods for diagnosing or prognosticating SARS-CoV-2 infection and/or COVID-19 in a subject. The methods set forth improved immunoassays, sensing platforms, and methods for detecting SARS-CoV-2 infection and re-infection.
    Type: Grant
    Filed: June 15, 2021
    Date of Patent: May 9, 2023
    Assignee: Nirmidas Biotech, Inc.
    Inventors: Meijie Tang, Hongjie Dai, Tiancheng Liu, Jessica Hsiung, Jessica Kost, Deepika Sreedhar, Su Zhao
  • Methods and systems for diagnosis and treatment of viral infections
    Patent number: 11022611
    Abstract: Disclosed herein are systems and methods for detecting and diagnosing flaviviral or alphaviral infections in subjects in need thereof. The systems and methods of the disclosure enable rapid testing of small volumes of biological sample with the ability to reliably distinguish between flavival and alphaviral infections and determine whether the viral infection is acute or chronic.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: June 1, 2021
    Assignee: Nirmidas Biotech, Inc.
    Inventors: Joshua T. Robinson, Meijie Tang, Su Zhao, Anna Hsu Pao, Hongjie Dai, Bo Zhang, Jeyarama Subramanian Ananta Narayanan